World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   16501 records for 3799 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
Not recruitingNCT02870140
Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent
12/08/2016
Not RecruitingCTRI/2016/07/007090
TWILIGHT Study The anti platelet therapy with both ticagrelor and aspirin for 3 months after coronary intervention followed by ticagrelor only for a year rather than both aspirin and ticagrelor is better in reducing the ischemic events in high risk patients.
13-07-2016
RecruitingNCT02833350
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
12/07/2016
AuthorisedEUCTR2015-001641-89-GR
Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin (DOX) versus Cyclophosphamide (CTX), Doxorubicin (DOX) and Vincristine (VCR) (CAV) or Topotecan as Treatment in Patients with Small-Cell Lung Cancer (SCLC) 05/07/2016
Not RecruitingCTRI/2016/06/007041
Biosimilar Study on Lung Cancer
27-06-2016
Not RecruitingCTRI/2016/06/007031
Usefulness and safety of Faster-acting Insuin Aspart is being compared to NovoRapid (Fast acting insulin) both in combination with marketed product Tresiba (Insulin Degludec) in adults with Type-1 diabetes.
22-06-2016
AuthorisedEUCTR2016-000393-37-BG
A study to test the effectiveness of bimekizumab as a treatment for rheumatoid arthritis, to look for unwanted side effects and to measure how the drug is distributed, modified and cleared from the body.
17/06/2016
AuthorisedEUCTR2016-000390-20-PL
English A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Symptomatic Ulcerative Colitis Patients with Moderate to Severe Disease Activity 16/06/2016
AuthorisedEUCTR2015-003034-27-BE
DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF CRENEZUMAB IN PATIENTS WITH PRODROMAL- TO-MILD ALZHEIMER’S DISEASE
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2015-003034-27-ESDOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF CRENEZUMAB IN PATIENTS WITH PRODROMAL- TO-MILD ALZHEIMER?S DISEASE17/05/2016
16/06/2016
Not RecruitingJPRN-JapicCTI-152879
THEMIS
Recruitment statusMain IDPublic titleDate of registration
Not recruitingNCT01991795A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus18/11/2013
14/06/2016
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history